1. Home
  2. PSFE vs TOI Comparison

PSFE vs TOI Comparison

Compare PSFE & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Paysafe Limited

PSFE

Paysafe Limited

HOLD

Current Price

$7.18

Market Cap

390.7M

ML Signal

HOLD

Logo The Oncology Institute Inc.

TOI

The Oncology Institute Inc.

HOLD

Current Price

$3.23

Market Cap

327.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSFE
TOI
Founded
1996
2007
Country
United Kingdom
United States
Employees
2900
N/A
Industry
Business Services
Medical/Nursing Services
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
390.7M
327.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PSFE
TOI
Price
$7.18
$3.23
Analyst Decision
Hold
Strong Buy
Analyst Count
4
3
Target Price
$8.69
$6.67
AVG Volume (30 Days)
397.0K
2.1M
Earning Date
03-03-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$8.26
$27.81
Revenue Next Year
$6.30
$25.94
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.95
$1.03
52 Week High
$18.15
$4.88

Technical Indicators

Market Signals
Indicator
PSFE
TOI
Relative Strength Index (RSI) 52.73 56.08
Support Level $6.61 $3.22
Resistance Level $7.39 $3.58
Average True Range (ATR) 0.35 0.31
MACD 0.00 0.07
Stochastic Oscillator 39.47 53.90

Price Performance

Historical Comparison
PSFE
TOI

About PSFE Paysafe Limited

Paysafe Ltd is an integrated payments platform. Its core purpose is to enable businesses and consumers to connect and transact seamlessly through capabilities in payment processing, digital wallet, and online cash solutions. The company provides payment solutions through three primary lines of business: Integrated Processing, Digital Wallet and eCash Solutions. It derives a majority of revenue from the USA followed by Germany, the UK, and all other countries.

About TOI The Oncology Institute Inc.

The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.

Share on Social Networks: